Amyvid

Product NDC: 0002-1200
11-digit product format: 000021200
Labeler code: 0002
Product ID: 0002-1200_63e1d0b5-c634-4699-91b2-643a6e765139
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Florbetapir F 18
Dosage form: INJECTION, SOLUTION
Route: INTRAVENOUS
Labeler: Eli Lilly and Company
Application: NDA202008
Marketing category: NDA
Marketing start: 2012-06-01
Substance: FLORBETAPIR F-18
Active strength: 51 mCi/mL
Pharmacologic classes: Positron Emitting Activity [MoA], Radioactive Diagnostic Agent [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N202008-001	AMYVID	FLORBETAPIR F-18	10ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD	2012-04-06
N202008-002	AMYVID	FLORBETAPIR F-18	10-30ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD	2012-04-06
N202008-003	AMYVID	FLORBETAPIR F-18	10-50ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2012-04-06
N202008-004	AMYVID	FLORBETAPIR F-18	10-100ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2023-10-13

Orange Book patents#

Current patent rows page 1 of 1 · 8 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N202008-001	7687052	2027-04-30	U-4217	Drug substance, Drug product	2012-05-04
N202008-001	8506929	2027-04-30	U-4217	Drug substance, Drug product	2013-09-06
N202008-002	7687052	2027-04-30	U-4217	Drug substance, Drug product
N202008-002	8506929	2027-04-30	U-4217	Drug substance, Drug product
N202008-003	7687052	2027-04-30	U-4217	Drug substance, Drug product
N202008-003	8506929	2027-04-30	U-4217	Drug substance, Drug product
N202008-004	7687052	2027-04-30	U-4217	Drug substance, Drug product	2025-07-23
N202008-004	8506929	2027-04-30	U-4217	Drug substance, Drug product	2025-07-23

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 145 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N202008-001	AMYVID	10ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD	2012-04-06	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202008-002	AMYVID	10-30ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD	2012-04-06	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202008-003	AMYVID	10-50ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2012-04-06	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202008-004	AMYVID	10-100ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2023-10-13	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N202008-001	AMYVID	10ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD	2012-04-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202008-002	AMYVID	10-30ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD	2012-04-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202008-003	AMYVID	10-50ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2012-04-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202008-004	AMYVID	10-100ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2023-10-13	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202008-001	AMYVID	10ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD	2012-04-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202008-002	AMYVID	10-30ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD	2012-04-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202008-003	AMYVID	10-50ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2012-04-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202008-004	AMYVID	10-100ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2023-10-13	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N202008-001	AMYVID	10ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD	2012-04-06	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N202008-002	AMYVID	10-30ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD	2012-04-06	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N202008-003	AMYVID	10-50ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2012-04-06	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N202008-004	AMYVID	10-100ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2023-10-13	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N202008-001	AMYVID	10ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD	2012-04-06	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N202008-002	AMYVID	10-30ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD	2012-04-06	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N202008-003	AMYVID	10-50ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2012-04-06	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N202008-004	AMYVID	10-100ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2023-10-13	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N202008-001	AMYVID	10ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD	2012-04-06	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N202008-002	AMYVID	10-30ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD	2012-04-06	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N202008-003	AMYVID	10-50ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2012-04-06	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N202008-004	AMYVID	10-100ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2023-10-13	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N202008-001	AMYVID	10ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD	2012-04-06	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N202008-002	AMYVID	10-30ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD	2012-04-06	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N202008-003	AMYVID	10-50ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2012-04-06	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N202008-004	AMYVID	10-100ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2023-10-13	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N202008-001	AMYVID	10ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD	2012-04-06	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N202008-002	AMYVID	10-30ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD	2012-04-06	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N202008-003	AMYVID	10-50ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2012-04-06	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N202008-004	AMYVID	10-100ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2023-10-13	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N202008-001	AMYVID	10ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD	2012-04-06	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N202008-002	AMYVID	10-30ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD	2012-04-06	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N202008-003	AMYVID	10-50ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2012-04-06	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N202008-004	AMYVID	10-100ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2023-10-13	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N202008-001	AMYVID	10ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD	2012-04-06	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N202008-002	AMYVID	10-30ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD	2012-04-06	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N202008-003	AMYVID	10-50ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2012-04-06	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N202008-004	AMYVID	10-100ML (13.5-51mCi/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2023-10-13	`d8e5a09893c0…`

Observed Orange Book patent history#

Patent history page 1 of 7 · 262 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-08-18 06:07:40	2026-07	N202008-001	7687052	2027-04-30	U-4217	Drug substance, Drug product	2012-05-04	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202008-001	8506929	2027-04-30	U-4217	Drug substance, Drug product	2013-09-06	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202008-002	7687052	2027-04-30	U-4217	Drug substance, Drug product		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202008-002	8506929	2027-04-30	U-4217	Drug substance, Drug product		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202008-003	7687052	2027-04-30	U-4217	Drug substance, Drug product		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202008-003	8506929	2027-04-30	U-4217	Drug substance, Drug product		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202008-004	7687052	2027-04-30	U-4217	Drug substance, Drug product	2025-07-23	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202008-004	8506929	2027-04-30	U-4217	Drug substance, Drug product	2025-07-23	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N202008-001	7687052	2027-04-30	U-4217	Drug substance, Drug product	2012-05-04	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202008-001	8506929	2027-04-30	U-4217	Drug substance, Drug product	2013-09-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202008-002	7687052	2027-04-30	U-4217	Drug substance, Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202008-002	8506929	2027-04-30	U-4217	Drug substance, Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202008-003	7687052	2027-04-30	U-4217	Drug substance, Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202008-003	8506929	2027-04-30	U-4217	Drug substance, Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202008-004	7687052	2027-04-30	U-4217	Drug substance, Drug product	2025-07-23	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202008-004	8506929	2027-04-30	U-4217	Drug substance, Drug product	2025-07-23	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202008-001	7687052	2027-04-30	U-4217	Drug substance, Drug product	2012-05-04	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202008-001	8506929	2027-04-30	U-4217	Drug substance, Drug product	2013-09-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202008-002	7687052	2027-04-30	U-4217	Drug substance, Drug product		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202008-002	8506929	2027-04-30	U-4217	Drug substance, Drug product		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202008-003	7687052	2027-04-30	U-4217	Drug substance, Drug product		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202008-003	8506929	2027-04-30	U-4217	Drug substance, Drug product		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202008-004	7687052	2027-04-30	U-4217	Drug substance, Drug product	2025-07-23	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202008-004	8506929	2027-04-30	U-4217	Drug substance, Drug product	2025-07-23	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N202008-001	7687052	2027-04-30	U-4217	Drug substance, Drug product	2012-05-04	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N202008-001	8506929	2027-04-30	U-4217	Drug substance, Drug product	2013-09-06	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N202008-002	7687052	2027-04-30	U-4217	Drug substance, Drug product		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N202008-002	8506929	2027-04-30	U-4217	Drug substance, Drug product		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N202008-003	7687052	2027-04-30	U-4217	Drug substance, Drug product		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N202008-003	8506929	2027-04-30	U-4217	Drug substance, Drug product		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N202008-004	7687052	2027-04-30	U-4217	Drug substance, Drug product	2025-07-23	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N202008-004	8506929	2027-04-30	U-4217	Drug substance, Drug product	2025-07-23	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N202008-001	7687052	2027-04-30		Drug substance, Drug product	2012-05-04	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N202008-001	8506929	2027-04-30	U-1423	Drug substance, Drug product	2013-09-06	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N202008-002	7687052	2027-04-30		Drug substance, Drug product		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N202008-002	8506929	2027-04-30	U-1423	Drug substance, Drug product		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N202008-003	7687052	2027-04-30		Drug substance, Drug product		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N202008-003	8506929	2027-04-30	U-1423	Drug substance, Drug product		`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N202008-001	7687052	2027-04-30		Drug substance, Drug product	2012-05-04	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N202008-001	8506929	2027-04-30	U-1423	Drug substance, Drug product	2013-09-06	`b8a1b40f171c…`

Additional Listing Data#

Finished product: Yes
Brand name base: Amyvid
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
FLORBETAPIR F-18	51 mCi/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6W15Z5R0RU	Internal UNII lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
bb5a5043-0f51-11df-8a39-0800200c9a66	Available on FDA.report

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0002-1200-48	Amyvid	100 mL in 1 VIAL, MULTI-DOSE	INJECTION, SOLUTION	100	25
0002-1200-48	Amyvid	1 in 1 CAN	INJECTION, SOLUTION	1	25
0002-1200-50	Amyvid	50 mL in 1 VIAL, MULTI-DOSE	INJECTION, SOLUTION	50	25
0002-1200-50	Amyvid	1 in 1 CAN	INJECTION, SOLUTION	1	25

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0002-1200-50	EA - Each	0002-1200	f47357cf-6fff-44fd-aa65-c55d386d508f	1	2024-02-14

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
FLORBETAPIR F-18	ACTIVE INGREDIENT	6W15Z5R0RU	AMYVID (FLORBETAPIR F 18) INJECTION, SOLUTION [ELI LILLY AND COMPANY]	8
FLORBETAPIR F-18	ACTIVE MOIETY	6W15Z5R0RU	AMYVID (FLORBETAPIR F 18) INJECTION, SOLUTION [ELI LILLY AND COMPANY]	8
Alcohol	INACTIVE INGREDIENT	3K9958V90M	AMYVID (FLORBETAPIR F 18) INJECTION, SOLUTION [ELI LILLY AND COMPANY]	8
Sodium Ascorbate	INACTIVE INGREDIENT	S033EH8359	AMYVID (FLORBETAPIR F 18) INJECTION, SOLUTION [ELI LILLY AND COMPANY]	8
Sodium Chloride	INACTIVE INGREDIENT	451W47IQ8X	AMYVID (FLORBETAPIR F 18) INJECTION, SOLUTION [ELI LILLY AND COMPANY]	8

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0002-1200	AMYVID (FLORBETAPIR F 18) INJECTION, SOLUTION [ELI LILLY AND COMPANY]	22	Current NDC, Legacy NDC, 4 package rows	20241115_bb5a5043-0f51-11df-8a39-0800200c9a66.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Amyvid	FLORBETAPIR F 18	Eli Lilly and Company	bb5a5043-0f51-11df-8a39-0800200c9a66	2025-12-11	Warnings, Adverse reactions	Exact identifier application applno (NDA): 202008 application number: NDA202008 ndc (product): 0002-1200

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6W15Z5R0RU	FLORBETAPIR F-18	956103-76-7	FLORBETAPIR F-18

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0002-1200-30	00002120030	1 VIAL, MULTI-DOSE in 1 CAN (0002-1200-30) > 30 mL in 1 VIAL, MULTI-DOSE	2012-06-01	0000-00-00	No	No	Current
0002-1200-48	00002120048	1 VIAL, MULTI-DOSE in 1 CAN (0002-1200-48) / 100 mL in 1 VIAL, MULTI-DOSE	2023-05-22		No	No	Current
0002-1200-50	00002120050	1 VIAL, MULTI-DOSE in 1 CAN (0002-1200-50) / 50 mL in 1 VIAL, MULTI-DOSE	2012-06-01	0000-00-00	No	No	Current